Neural hyperactivation in carriers of the Alzheimer's risk variant on the clusterin gene

European Neuropsychopharmacology

Volumn 21, Issue 12, 2011, Pages 880-884

  Lancaster, Thomas M ^a   Baird, Alison ^b   Wolf, Claudia ^c   Jackson, Margaret C ^c   Johnston, Stephen J ^d   Donev, Rossen ^b   Thome, Johannes ^b   Linden, David E J ^a,c,e  

^a BANGOR UNIVERSITY   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c BANGOR UNIVERSITY   (United Kingdom)

^d BRUNEL UNIVERSITY   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Clusterin; Dementia; Genetic imaging; Hippocampus; Prefrontal cortex; Working memory

Indexed keywords

CLUSTERIN;

ADULT; ALLELE; ALZHEIMER DISEASE; ARTICLE; CINGULATE GYRUS; DISEASE CARRIER; DISEASE COURSE; DISEASE MODEL; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC VARIABILITY; GENOTYPE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK; WORKING MEMORY;

ADOLESCENT; ADULT; ALZHEIMER DISEASE; CLUSTERIN; FEMALE; GENETIC VARIATION; HETEROZYGOTE; HUMANS; MALE; MEMORY; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 80052755526     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2011.02.001     Document Type: Article

References (28)

1. Bertram L., Tanzi R.E. Genome-wide association studies in Alzheimer's disease. Human Molecular Genetics 2009, 18(R2):R137-R145.
2. Bertram L., Tanzi R.E. Alzheimer disease: new light on an old CLU. Nature Reviews. Neurology 2010, 6(1):11-13.
3. Biffi A., Anderson C.D., Desikan R.S., Sabuncu M., Cortellini L., Schmansky N., et al. Genetic variation and neuroimaging measures in Alzheimer disease. Archives of Neurology 2010, 67(6):677-685.
4. Bondi M.W., Houston W.S., Eyler L.T., Brown G.G. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 2005, 64(3):501-508.
5. Bookheimer S., Burggren A. APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging. Annual Review of Clinical Psychology 2009, 5:343-362.
6. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., et al. Patterns of brain activation in people at risk for Alzheimer's disease. The New England Journal of Medicine 2000, 343(7):450-456.
7. Braak H., Braak E. Evolution of neuronal changes in the course of Alzheimer's disease. Journal of Neural Transmission. Supplementum 1998, 53:127-140.
8. Carrasquillo M.M., Belbin O., Hunter T.A., Ma L., Bisceglio G.D., Zou F., et al. Replication of CLU, CR1, and PICALM associations with Alzheimer disease. Archives of Neurology 2010, 67(8):961-964.
9. Cheung K.H., Shineman D., Muller M., Cardenas C., Mei L., Yang J., et al. Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating. Neuron 2008, 58(6):871-883.
10. Corneveaux J.J., Myers A.J., Allen A.N., Pruzin J.J., Ramirez M., Engel A., et al. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Human Molecular Genetics 2010, 19(16):3295-3301.
11. Cowburn R.F., Popescu B.O., Ankarcrona M., Dehvari N., Cedazo-Minguez A. Presenilin-mediated signal transduction. Physiology & Behavior 2007, 92(1-2):93-97.
12. Donev R., Kolev M., Millet B., Thome J. Neuronal death in Alzheimer's disease and therapeutic opportunities. Journal of Cellular and Molecular Medicine 2009, 13(11-12):4329-4348.
13. Girouard H., Iadecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. Journal of Applied Physiology (Bethesda, Md. 1985, 100(1):328-335.
14. Hariri A.R., Weinberger D.R. Imaging genomics. Br Med Bull 2003, 65:259-270.
15. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics 2009, 41(10):1088-1093.
16. Jackson M.C., Wu C.Y., Linden D.E., Raymond J.E. Enhanced visual short-term memory for angry faces. Journal of Experimental Psychology. Human Perception and Performance 2009, 35(2):363-374.
17. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nature Genetics 2009, 41(10):1094-1099.
18. Lancaster J.L., Woldorff M.G., Parsons L.M., Liotti M., Freitas C.S., Rainey L., et al. Automated talairach atlas labels for functional brain mapping. Human Brain Mapping 2000, 10(3):120-131.
19. Prvulovic D., Van de Ven V., Sack A.T., Maurer K., Linden D.E. Functional activation imaging in aging and dementia. Psychiatry Research 2005, 140(2):97-113.
20. Rasch B., Papassotiropoulos A., de Quervain D.F. Imaging genetics of cognitive functions: focus on episodic memory. NeuroImage 2010, 53(3):870-877.
21. Seidenberg M., Guidotti L., Nielson K.A., Woodard J.L., Durgerian S., Antuono P., et al. Semantic memory activation in individuals at risk for developing Alzheimer disease. Neurology 2009, 73(8):612-620.
22. Small G.W., Ercoli L.M., Silverman D.H., Huang S.C., Komo S., Bookheimer S.Y., et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc. of. The. Nat. Acad. Of. Sci. USA 2000, 97(11):6037-6042.
23. Smith J.C., Nielson K.A., Woodard J.L., Seidenberg M., Durgerian S., Antuono P., et al. Interactive effects of physical activity and APOE-epsilon4 on BOLD semantic memory activation in healthy elders. NeuroImage 2011, 54(1):635-644.
24. Thambisetty M., Simmons A., Velayudhan L., Hye A., Campbell J., Zhang Y., et al. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Archives of General Psychiatry 2010, 67(7):739-748.
25. Werheid K., Clare L. Are faces special in Alzheimer's disease? Cognitive conceptualisation, neural correlates, and diagnostic relevance of impaired memory for faces and names. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior 2007, 43(7):898-906.
26. Wierenga C.E., Stricker N.H., McCauley A., Simmons A., Jak A.J., Chang Y.L., et al. Increased functional brain response during word retrieval in cognitively intact older adults at genetic risk for Alzheimer's disease. NeuroImage 2010, 51(3):1222-1233.
27. Wishart H.A., Saykin A.J., Rabin L.A., Santulli R.B., Flashman L.A., Guerin S.J., et al. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele. The American Journal of Psychiatry 2006, 163(9):1603-1610.
28. Wolf, C., Jackson, M.C., Kissling, C., Thome, J., Linden, D.E., 2011. Dysbindin-1 genotype effects on emotional working memory. Molecular Psychiatry 16 (2), 145-155.